Research and Markets: Pet Medications in the U.S 4th Edition – In-Depth Coverage of Competitive Trends, New Product Trends and Marketing Activity

DUBLIN–(BUSINESS WIRE)–Research and Markets (
has announced the addition of the “Pet
Medications in the U.S., 4th Edition”
report to their offering.

The market for pet medications in the U.S. has entered a period of
redefinition and renewal. Merial’s Frontline Plus is still the market
leader in flea and tick medication, but it has a number of copycat
competitors, selling at far less than the now off-patent powerhouse. But
Merial has managed to not only stem the losses, but also gain back share
via a new flea and tick blockbuster, Nexgard. In other areas, Zoetis
introduced a blockbuster of its own, the anti-itch drug APOQUEL, and has
had trouble meeting demand. The industry has also enjoyed the entrance
of a wave of animal health start-ups, and a number of new drugs appear
to be on the horizon.

The pet medication space has also seen considerable investment action,
from the position taken in Zoetis by the hedge fund of activist investor
William Ackman to the sale of Novartis Animal Health’s assets to Elanco
and Virbac.

In its fourth edition, Pet Medications in the U.S. analyzes the market
for prescription and over-the-counter medications for dogs and cats,
with a particular focus on brand-name products used by consumers and on
antiparasitics. Areas covered include parasite prevention and control
(flea, tick, heartworm, etc.), cancer, pain management, behavioral
health, diabetes, cognitive dysfunction, heart health, ear care and
allergies. The report provides in-depth coverage of competitive trends,
new product trends and marketing activity, and draws on insights from
other reports in Packaged Facts’ extensive Pet Market Collection.
Statistics provided include historical and projected market revenues,
along with demographics and psychographics of pet med purchasers, based
on data from sources including Simmons and Packaged Facts own pet owner

Key Topics Covered:

Chapter 1: Executive Summary

Chapter 2: Market Trends

Chapter 3: The Marketers

Chapter 4: Retail Trends

Chapter 5: Consumer Trends

For more information visit


Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals,